Vaccine-preventable disease (VPD) surveillance should be a priority throughout the world. In Italy, however, there is limited attention to the epidemiology of VPDs, with the consequence that their incidence is largely underestimated. Although notification of vaccine-preventable diseases is mandatory, very often the etiologic agents causing VPDs are not identified the etiological agents causing the major and most severe infectious diseases in childhood. Several reasons underlie the underestimation. For example, not having a good surveillance system does not allow us to organize a sustainable prevention project for example based on on the introduction of new vaccinations. For example the limited use of low-cost high-sensitivity techniques such as real-time PCR, which could, if more widely used, improve pathogen identification with 3 times the sensitivity of standard cultural methods. Therefore, the idea of this multicenter, biological sample study is to take advantage of the regional pediatric network with the goal of improving VPD surveillance and increase awareness of the importance of surveillance of preventable diseases with the vaccine within the pediatric network.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
1
Confermation of type of infection with RT-PCR.
Ospedale San Donato
Arezzo, Italy
RECRUITINGImmunology Laboratory Meyer Children's Hospital, IRCCS
Florence, Italy
RECRUITINGMeyer Children's Hospital IRCCS
Florence, Italy
RECRUITINGUO Pediatria Universitaria Ospedale S.Chiara
Pisa, Italy
RECRUITINGIncidence rate of major VPDs (vaccine-preventable infectious diseases): pertussis, influenza virus, respiratory syncytial virus, S.pneumoniae, N.meningitidis, H.influenzae.
Molecular surveillance data analysis of pertussis, respiratory virus disease, invasive bacterial diseases. We will measure the incidence rate of predictable disease with vaccination, stratifying by biological sex, age, other risk factors, and severity of infection during the project. (IBD) due to capsule bacteria (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae) and other vaccine-preventable infections (e.g., viral flu)
Time frame: After 3 years from the beginning of the study
Frequency of principal serotype, serogroups of pathogens causative for VPDs.
Analysis of molecular characteristics of germs identified in pediatric subjects with VPDs.
Time frame: After 3 years from the beginning of the study
Number of meeting to diffuse the NETVAC results in Tuscany network.
Expand and spread knowledge of the importance of active and molecular surveillance in the pediatric network consisting of hospital centers and family pediatricians in Tuscany through the organization of at least two meetings/year for three years between centers hospitals in Tuscany, family pediatricians within the regional pediatric network and pediatric scientific societies in order to disseminate the role of molecular diagnosis in the active surveillance against vaccine-preventable infectious diseases.
Time frame: After 3 years and 6 months from the beginning of the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.